Unknown

Dataset Information

0

Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.


ABSTRACT:

Background

Survivors of childhood cancer have an increased risk of therapy-related cardiovascular disease. It is not known whether family history of cardiovascular disease further increases risk of adverse cardiovascular outcomes among survivors.

Methods

Family history of cardiovascular disease was collected from 1,260 survivors [median age at diagnosis, 8 years (range, 0-23); age at last follow-up, 35 years (range, 18-66)] of childhood cancer in the St. Jude Lifetime Cohort Study. Multivariable risk models evaluated associations with cardiovascular disease (Common Terminology Criteria for Adverse Events grade 2-4 events) and cardiovascular risk factors.

Results

Among survivors exposed to chest-directed radiation and/or anthracycline chemotherapy (n = 824), 7% reported a first-degree family history of heart failure, 19% myocardial infarction, 11% stroke, 26% atherosclerotic disease (myocardial infarction and/or stroke), 62% hypertension, and 31% diabetes mellitus. Eighteen percent of exposed survivors developed heart failure, 9% myocardial infarction, 3% stroke, 11% atherosclerotic disease, 30% hypertension, and 9% diabetes mellitus. Having a first-degree family history of atherosclerotic disease was independently associated with development of treatment-related heart failure [RR, 1.38; 95% confidence interval (CI), 1.01-1.88; P = 0.04] among exposed survivors. Risk for hypertension was increased among exposed survivors with a first-degree family history of hypertension (RR, 1.55; 95% CI, 1.26-1.92; P < 0.0001) or of any cardiovascular disease [myocardial infarction, stroke, or heart failure (RR, 1.30; 95% CI, 1.06-1.59; P = 0.01)].

Conclusions

Family history of cardiovascular disease and cardiovascular risk factors independently increased risk of heart failure and hypertension among survivors of childhood cancer exposed to cardiotoxic therapies.

Impact

These data show the importance of cardiovascular family history as a risk factor for cardiovascular disease in survivors of childhood cancer.

SUBMITTER: Goldberg JF 

PROVIDER: S-EPMC7855495 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.

Goldberg Jason F JF   Ness Kirsten K KK   Chi Xiaofei X   Santucci Aimee K AK   Plana Juan Carlos JC   Joshi Vijaya M VM   Luepker Russell V RV   Durand Jean-Bernard JB   Partin Robyn E RE   Howell Rebecca M RM   Wilson Carmen L CL   Towbin Jeffrey A JA   Jefferies John L JL   Srivastava Deo Kumar DK   Hudson Melissa M MM   Robison Leslie L LL   Armstrong Gregory T GT  

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20201008 1


<h4>Background</h4>Survivors of childhood cancer have an increased risk of therapy-related cardiovascular disease. It is not known whether family history of cardiovascular disease further increases risk of adverse cardiovascular outcomes among survivors.<h4>Methods</h4>Family history of cardiovascular disease was collected from 1,260 survivors [median age at diagnosis, 8 years (range, 0-23); age at last follow-up, 35 years (range, 18-66)] of childhood cancer in the St. Jude Lifetime Cohort Study  ...[more]

Similar Datasets

| S-EPMC5413397 | biostudies-literature
| S-EPMC8310532 | biostudies-literature
| S-EPMC5403569 | biostudies-literature
| S-EPMC8453382 | biostudies-literature
| S-EPMC8633430 | biostudies-literature
| S-EPMC11520214 | biostudies-literature
| S-EPMC7552816 | biostudies-literature
| S-EPMC7302420 | biostudies-literature
| S-EPMC11429751 | biostudies-literature
| S-EPMC8059051 | biostudies-literature